← Eichor
Study identifier: NCT06836128 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients

Condition: Polycystic Ovary Syndrome  ·  Sponsor: Cairo University

PhasePhase 3
Planned participants102
Who can joinFemale, 20 Years to 45 Years
Healthy volunteersNo

About this study

The study aims to evaluate the effects of combination of metformin with NAC in PCOS on biochemical and hormonal parameters.

This description comes directly from the study's public registry record.

Talk to the study team

Marwa R Talat, BPharm  ·  +201069342847  ·  marwa.rafat@pharma.cu.edu.eg

Eglal A Mostafa Bassiouny, PhD  ·  +201061500242  ·  eglal.mostafa@pharma.cu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Kasr El-Ainy hospitalCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06836128